Ceva launched sow vaccine against Neonatal Diarrhoea with 7 antigens inside >

Ceva launched sow vaccine against Neonatal Diarrhoea with 7 antigens inside >

Press release, March 9th, 2022

European Patent Office decides in Ceva’s favour clearing the way for the launch of ForcerisTM across Europe. >

Covid-19 Message to our customers >

To all our Swine customers, I wanted to address you directly to thank you for everything you do in putting food on our tables, especially during this crisis. Our industry has never seen such a difficult year with the “double punch” - first of African Swine Fever, where we lost 1 in 4 of the world’s sows and then the Covid-19 pandemic directly threatening our own lives. Through all this you have and...

New test speeds up fight against salmonella on pig farms >

25th International Pig Veterinary Society Congress >

IPVS 2018.6.11-4.14

Ceva “Spotlights the Future” at ESPHM2018 Barcelona, demonstrating its strong progress to become one of Europe’s leading suppliers of swine vaccines >

Ceva’s rapid development as a major player in the European swine sector was further underlined with a strong scientific showing during the symposium.

Ceva in position to acquire key brands from Boehringer Ingelheim, as a result of Merial purchase >

Ceva in position to acquire key brands from Boehringer Ingelheim, as a result of Merial purchase Following several weeks of intensive negotiations by Ceva's senior management team, Boehringer Ingelheim have endorsed the sale of a number of key Merial brands to Ceva. Details of the transaction are contained in the attached press release. >> Download the press release issued by Boehringer Ingelheim...

CEVA ACQUIRES BIOVAC, LEADING FRENCH MANUFACTURER OF AUTOGENOUS VACCINES >

Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics

Ceva reports annual growth of 12% and reaffirms ambition to enter the global top 5 by 2020 >

Raft of new product launches across significant markets powers strong sales in 2015